SHARE Program: SUSTAIN
Launched by FLORIDA STATE UNIVERSITY · Apr 11, 2025
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The SHARE Program: SUSTAIN trial is studying ways to help young people living with HIV manage their health better, especially when it comes to medication adherence and alcohol use. The program uses mobile health technology (like apps and text messaging) to support participants in making healthier choices. The main goal is to help participants take their HIV medications daily and reduce risky alcohol use, with the hope that this will also lead to better health outcomes, such as viral suppression (meaning the virus is controlled and not spreading).
To participate in this trial, individuals must be between 18 and 29 years old, live in Florida, have a history of alcohol use, and be able to read and understand English. They also need to have access to the internet through a smartphone, tablet, or computer. Participants will engage in sessions that include guidance on healthy choices and receive support through text messages. This study is currently recruiting and aims to create a program that can be widely used to help others in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Be 18 years and 0 months to 29 years and 11 months.
- • Currently reside in Florida
- • History of alcohol use
- • Are not pregnant nor trying to conceive within the study's timeline
- • Are able to read and understand English
- • Have internet access via smartphone, tablet or computer
- • Are willing to provide informed consent.
- Exclusion Criteria:
- • Adults unable to consent
- • Prisoners
- • Those using long-acting injectables as HIV medication regimen
About Florida State University
Florida State University (FSU) is a prestigious public research institution located in Tallahassee, Florida, known for its commitment to advancing knowledge and innovation in various fields, including health sciences. As a clinical trial sponsor, FSU leverages its extensive academic resources and expertise to conduct rigorous research aimed at improving patient outcomes and contributing to the medical community. The university fosters a collaborative environment that brings together multidisciplinary teams to design, implement, and analyze clinical studies, ensuring adherence to the highest ethical and scientific standards. Through its clinical trials, FSU aims to address critical health challenges and translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Tampa, Florida, United States
Boston, Massachusetts, United States
Tallahassee, Florida, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported